Close

Publications

Quantifying incidence and pathways across TB disease states following Mtb infection.
Horton, K; Emery, JC; RICHARDS, AS; Esmail, H; HOUBEN, R;
2022
(2022).
Zar, H; MacGinty, R; Workman, L; Botha, M; Johnson, M; Hunt, A; Burd, T; Nicol, M; FLASCHE, S; Quilty, B; Goldblatt, D;
2022
Emes, ET; Dang-Xuan, S; Le, TT-H; Waage, J; KNIGHT, G; Naylor, N;
2022
Elsevier BV (2022). 10.2139/ssrn.4104382.
VAN Trang, N; PREM, K; Toh, ZQ; Viet Ha, BT; Ngoc Lan, PT; Tran, HP; Pham, QD; VAN Khuu, N; JIT, M; Luu, DT; Khanh Ly, LE T; Cao, VA N; LE-Ha, T-D; Bright, K; Garland, SM; Anh, DD; MULHOLLAND, K;
2021
In vivo (Athens, Greece), (2021).36 1 10.21873/invivo.12697.
Real-time estimation of the time-varying transmission advantage of Omicron in England using S-Gene Target Status as a Proxy.
ABBOTT, S; Sherratt, K; FUNK, S;
2021
(2021).
THINDWA, D; Wolter, N; Pinsent, A; Carrim, M; Ojal, J; Tempia, S; Moyes, J; McMorrow, M; Kleynhans, J; Gottberg, AV; French, N; PHIRST group,; Cohen, C; FLASCHE, S;
2021
PLOS COMPUTATIONAL BIOLOGY, (2021).17 12 10.1371/journal.pcbi.1009680.
Real-time estimation of the time-varying transmission advantage of Omicron in England using S-Gene Target Status as a Proxy.
ABBOTT, S; Sherratt, K; FUNK, S;
2021
, Zenodo (2021).
Rowan, A; Bates, C; Hulme, W; Evans, D; Davy, S; A Kennedy, N; Galloway, J; E Mansfield, K; Bechman, K; MATTHEWMAN, J; Yates, M; Brown, J; SCHULTZE, A; Norton, S; J. Walker, A; E. Morton, C; BHASKARAN, K; T. Rentsch, C; WILLIAMSON, E; Croker, R; Bacon, S; Hickman, G; Ward, T; Green, A; Fisher, L; ... GOLDACRE, B.
2021
Wellcome Open Research, (2021).6, 10.12688/wellcomeopenres.17360.1.